.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Dow
AstraZeneca
Novartis
Harvard Business School
US Department of Justice
Accenture
Queensland Health
Moodys

Generated: January 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: eprosartan mesylate; hydrochlorothiazide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
AbbvieTEVETEN HCTeprosartan mesylate; hydrochlorothiazideTABLET;ORAL021268NDAPhysicians Total Care, Inc.54868-5281-130 TABLET in 1 BOTTLE (54868-5281-1)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Deloitte
Medtronic
Merck
Express Scripts
Chinese Patent Office

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot